These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15908834)

  • 41. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.
    Manos M; Frazier TW; Landgraf JM; Weiss M; Hodgkins P
    Curr Med Res Opin; 2009 Dec; 25(12):3001-10. PubMed ID: 19849639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.
    Mick E; McGough JJ; Middleton FA; Neale B; Faraone SV
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):466-72. PubMed ID: 21130132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
    Wilens TE; Hammerness P; Martelon M; Brodziak K; Utzinger L; Wong P
    J Clin Psychiatry; 2010 May; 71(5):548-56. PubMed ID: 20492851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR; Scott LJ
    Drugs; 2006; 66(8):1117-26. PubMed ID: 16789796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).
    Findling RL; Dinh S
    CNS Drugs; 2014 Mar; 28(3):217-28. PubMed ID: 24532028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
    Elia J; Wilson Z; La Porta LS; Algon SA; Prowler ML; Cartwright ST; McKenna PA; Laracy S; Takeda T; Borgmann-Winter K
    Expert Rev Clin Pharmacol; 2011 May; 4(3):311-28. PubMed ID: 22114778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder.
    Wilens TE; Boellner SW; López FA; Turnbow JM; Wigal SB; Childress AC; Abikoff HB; Manos MJ
    J Am Acad Child Adolesc Psychiatry; 2008 Jun; 47(6):700-708. PubMed ID: 18434918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.
    Marchant BK; Reimherr FW; Robison RJ; Olsen JL; Kondo DG
    J Atten Disord; 2011 May; 15(4):295-304. PubMed ID: 20410322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical assessment of the methylphenidate transdermal system.
    Kowalik S; Minami H; Silva RR
    Drugs Today (Barc); 2007 Aug; 43(8):515-27. PubMed ID: 17925883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluating medication response in ADHD: cognitive, behavioral, and single-subject methodology.
    Hale JB; Hoeppner JA; DeWitt MB; Coury DL; Ritacco DG; Trommer B
    J Learn Disabil; 1998; 31(6):595-607. PubMed ID: 9813958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analog classroom assessment of Adderall in children with ADHD.
    Swanson JM; Wigal S; Greenhill LL; Browne R; Waslik B; Lerner M; Williams L; Flynn D; Agler D; Crowley K; Fineberg E; Baren M; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1998 May; 37(5):519-26. PubMed ID: 9585654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of stimulants to treat ADHD: transdermal methylphenidate.
    Patrick KS; Straughn AB; Perkins JS; González MA
    Hum Psychopharmacol; 2009 Jan; 24(1):1-17. PubMed ID: 19051222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD.
    Scheres A; Oosterlaan J; Swanson J; Morein-Zamir S; Meiran N; Schut H; Vlasveld L; Sergeant JA
    J Abnorm Child Psychol; 2003 Feb; 31(1):105-20. PubMed ID: 12597703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD.
    Pelham WE; Burrows-MacLean L; Gnagy EM; Fabiano GA; Coles EK; Wymbs BT; Chacko A; Walker KS; Wymbs F; Garefino A; Hoffman MT; Waxmonsky JG; Waschbusch DA
    J Abnorm Child Psychol; 2014 Aug; 42(6):1019-31. PubMed ID: 24429997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.
    Greenhill LL; Abikoff HB; Arnold LE; Cantwell DP; Conners CK; Elliott G; Hechtman L; Hinshaw SP; Hoza B; Jensen PS; March JS; Newcorn J; Pelham WE; Severe JB; Swanson JM; Vitiello B; Wells K
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1304-13. PubMed ID: 8885584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical leukoderma after the application of a transdermal methylphenidate patch.
    Ghasri P; Gattu S; Saedi N; Ganesan AK
    J Am Acad Dermatol; 2012 Jun; 66(6):e237-8. PubMed ID: 22583724
    [No Abstract]   [Full Text] [Related]  

  • 58. Methylphenidate transdermal system in preschool children with attention-deficit/hyperactivity disorder.
    Ghuman JK; Byreddy S; Ghuman HS
    J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):495-8. PubMed ID: 22040197
    [No Abstract]   [Full Text] [Related]  

  • 59. Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.
    Faraone SV; Hammerness PG; Wilens TE
    J Atten Disord; 2018 Sep; 22(11):1040-1048. PubMed ID: 25575616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.
    Bell GH; Novak AJ; Griffin WC; Patrick KS
    J Pharm Sci; 2011 Jul; 100(7):2966-78. PubMed ID: 21240977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.